Given that lncRNA seems to be involved in various biologic processes, such as GC actions, inflammatory and autoimmune diseases, apoptosis and atherosclerosis, we speculate that lncRNA GAS5 decreased expression may be involved in the some typical phenotypes of DS patients. This evidence concerns the gene GAS5 and Dravet syndrome.